Morgan Stanley keeps Overweight on Shriram Finance stock

Shriram Finance stock was covered at Overweight by Morgan Stanley, which kept its target at INR 1,340 on October 8, 2026, according to NDTV Profit. The brokerage view gives investors a concrete benchmark while the company moves through a higher-rate backdrop.

Target rests on lower funding costs

According to NDTV Profit on October 8, 2026, Morgan Stanley viewed Shriram Finance as defensively positioned for a rate hike because net interest margins and earnings were seen as less affected. The report also pointed to lower incremental borrowing costs and reduced leverage after the MUFG transaction.

The same assessment highlighted a low share of floating-rate bank borrowings and limited exposure to insurance commissions relative to other non-bank lenders. That makes funding structure the key link between the INR 1,340 target and the operating figures investors will watch in the next quarter.

Revenue reaches INR 134.00 billion

Shriram Finance reported revenue of INR 134.00 billion in the first quarter of fiscal 2027, up 7.09 percent from INR 125.13 billion in the preceding quarter, according to Upstox. The comparison shows that the target is supported by measured top-line expansion rather than by a single market statistic.

Net profit rose 14.35 percent quarter over quarter to INR 34.47 billion in the first quarter of fiscal 2027 from INR 30.15 billion. Operating profit increased 18.08 percent to INR 46.26 billion from INR 39.17 billion over the same comparison, while the faster profit growth than revenue points to improved operating leverage.

NSE quote remains below yearly high

Shriram Finance was trading at INR 922.70 on the National Stock Exchange of India on October 8, 2026 at 2:47 p.m. IST, down 2.67 percent from the prior session close of INR 948.00. The quote stood between the 52-week range of INR 658.75 to INR 1,153.70, and the market capitalization was INR 2.2 trillion on the same date.

InvestPane lists October 30, 2026 as the next earnings date. That date will put the INR 1,340 target against the next reported quarter and offer a fresh test of revenue growth, profit expansion and funding-cost trends.